Celcuity, Inc. (CELC)
107.28
-1.02
(-0.94%)
USD |
NASDAQ |
Mar 03, 16:00
107.28
0.00 (0.00%)
After-Hours: 20:00
Celcuity Shareholders Equity (Quarterly) : 116.96M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Praxis Precision Medicines, Inc. | 878.14M |
| Rhythm Pharmaceuticals, Inc. | 139.07M |
| Apogee Therapeutics, Inc. | 586.34M |
| Arrowhead Pharmaceuticals, Inc. | 568.42M |
| Cogent Biosciences, Inc. | 636.37M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 476.00M |
| Total Liabilities (Quarterly) | 359.04M |
| Debt to Equity Ratio | 2.739 |
| Current Ratio | 12.26 |
| Net Debt Paydown Yield | -2.09% |